Table 1 Characteristics of included dialysis patients and healthy individuals as well as age-matched cohort for DVA.

From: Endothelial dysfunction in retinal vessels of hemodialysis patients compared to healthy controls

 

Whole cohorts

p-value

Age-matched cohorts for DVA

p-value

Healthy

Hemodialysis

Healthy

Hemodialysis

n

192

214

169

169

Age, years, mean ± SD

65.6 ± 12.5

62.6 ± 15.0

0.030

65.4 ± 12.7

65.4 ± 13.1

0.996

BMI, kg/m2, mean ± SD

24.4 ± 3.6

26.1 ± 5.5

 < 0.001

24.5 ± 3.6

26.4 ± 5.4

 < 0.001

Gender, male in %

41.7%

68.2%

 < 0.001

40.2%

67.5%

 < 0.001

Systolic blood pressure, mmHg, mean ± SD

132 ± 15

134 ± 22

0.252

132 ± 16

135 ± 22

0.219

Diastolic blood pressure, mmHg, mean ± SD

84 ± 10

74 ± 14

 < 0.001

84 ± 10

74 ± 15

 < 0.001

Mean blood pressure, mmHg, mean ± SD

105 ± 11

94 ± 15

 < 0.001

106 ± 11

94 ± 15

 < 0.001

eGFR (mean ± SD; CKD-EPI 2009; ml/min/1.73 m2)

76 ± 16

77 ± 15

Vascular disease*

0%

47.7%

0%

53.8%

Diabetes mellitus

0%

30.8%

0%

35.5%

Dialysis vintage in months, median [IQR]

48.5 [24.0–79.0]

42.0 [21.0–76.0]

Arterial hypertension in %

18.8%

94.4%

 < 0.001

20.7%

94.5%

 < 0.001

Hyperlipidemia in %

17.2%

57.9%

 < 0.001

17.8%

64.5%

 < 0.001

Nicotine abuse in %

20.3%

23.2%

0.494

20.7%

21.4%

0.881

Calcium channel blocker in medication in %

35.0%

36.1%

Vasodilator in medication in %

13.6%

14.2%

hsCRP, mg/dl, median [IQR]

0.13 [0.06–0.26]

0.36 [0.18–0.81]

 < 0.001

0.13 [0.06–0.26]

0.39 [0.19–0.92]

 < 0.001

  1. *Including coronary heart disease, peripheral artery disease, history of cerebrovascular events, arteriosclerosis.
  2. BMI body mass index, hsCRP high-sensitivity C-reactive protein, eGFR estimated glomerular filtration rate.